Physician profile
Daniel P Oconnor
NPI 1063070969
$6,886.29
in general payments reported to CMS, 2019-2025
14 companies · $435 in 2025
The $435 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2022: $333 · 2023: $2,538 · 2024: $3,458 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,147 · Food and Beverage: $2,284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,147.14 |
| Food and Beverage | $2,284.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $3,936.95 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medical Device Business Services, INC. | $514.78 | 2024 | |
| Glaxosmithkline, LLC. | $450.18 | 2021-2024 | Nucala |
| Becton, Dickinson and Company | $436.25 | 2024-2025 | Pristine, Powerpicc |
| Cook Incorporated | $394.28 | 2024 | Blue Rhino |
| Astrazeneca Pharmaceuticals LP | $316.54 | 2022-2024 | Airsupra |
| Pulmonx Corporation | $181.14 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Penumbra, INC. | $125.00 | 2023 | Indigo System |
| Grifols USA, LLC | $124.99 | 2023 | Xembify |
| Axsome Therapeutics, INC. | $124.74 | 2024 | Sunosi |
| Regeneron Healthcare Solutions, INC. | $115.99 | 2022 | |
| United Therapeutics Corporation | $109.50 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.43 | 2025 | |
| Bard Access Systems, INC. | $13.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Oconnor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.